Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Philips Persists With M&A Strategy; Snaps Up Ultrasound Dx Biz

Executive Summary

Philips is strengthening its hand in cardiac ultrasound with the addition of German ultrasound firm TomTec Imaging Systems, its seventh acquisition of the year. Financial terms of the deal were not disclosed.

You may also be interested in...



Philips' Scottish Digital Pathology Pilot Could Lead To Nationwide Deal

Philips is teaming up with NHS Glasgow & Clyde and NHS Lothian to pilot a national digital pathology service for Scotland. The pilot will last up to 12 months and is designed to establish a digitized national pathology service across Scottish hospitals.

M&A Analysis: July M&A Levels Reach Fever Pitch

The summer season is proving to be a hot one for medtech M&A activity, with another busy month of deal-making in July. Twenty-five deals were announced and closed during the month, surpassing June's deal count and making it the month with the highest M&A activity to date.

M&A Analysis: Philips Inks Trio Of Deals As Activity Levels Heat Up

It was a hot month for medtech M&A activity, with a total of 21 deals announced and closed in June. Dutch giant Philips continued its mission to grow its health-care business and inked three acquisitions, including a $2bn deal to buy vascular imaging business Spectranetics.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT105170

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel